All lobbying filings

BAVARIAN NORDIC INC.

Lobbying for BAVARIAN NORDIC INC.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · North Carolina · House · Senate · $130,000.00 expenses · posted Jan 23, 2026

Official filing document

Lobbying activity 7

Pharmacy

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Health Issues

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Medical/Disease Research/Clinical Labs

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Defense

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Disaster Planning/Emergencies

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Homeland Security

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Science/Technology

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem